These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27473218)

  • 1. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
    Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study.
    Nielsen R; Jorsal A; Iversen P; Tolbod LP; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Tarnow L; Kistorp C; Gustafsson I; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2019 Apr; 26(2):585-597. PubMed ID: 28770459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
    Masi S; Lautamäki R; Guiducci L; Di Cecco P; Porciello C; Pardini S; Morales MA; Chubuchny V; Salvadori PA; Emdin M; Sironi AM; Knuuti J; Neglia D; Nuutila P; Ferrannini E; Iozzo P
    Diabetologia; 2012 Sep; 55(9):2494-500. PubMed ID: 22752026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
    van den Heuvel AF; Bax JJ; Blanksma PK; Vaalburg W; Crijns HJ; van Veldhuisen DJ
    Cardiovasc Res; 2002 Jul; 55(1):97-103. PubMed ID: 12062712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
    Tavares de Melo MD; Giorgi MCP; Assuncao AN; Dantas RN; Araujo Filho JA; Parga Filho JR; Bierrenbach ALS; de Lima CR; Soares J; Meneguetti JC; Mady C; Hajjar LA; Kalil Filho R; Bocchi EA; Salemi VMC
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):915-921. PubMed ID: 28379356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report.
    Leccisotti L; Cinti F; Sorice GP; D'Amario D; Lorusso M; Guzzardi MA; Mezza T; Gugliandolo S; Cocchi C; Capece U; Indovina L; Ferraro PM; Iozzo P; Crea F; Giordano A; Giaccari A
    Cardiovasc Diabetol; 2022 Sep; 21(1):173. PubMed ID: 36057768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
    Mongillo M; John AS; Leccisotti L; Pennell DJ; Camici PG
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1172-7. PubMed ID: 17294189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
    Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.
    de Silva R; Yamamoto Y; Rhodes CG; Iida H; Nihoyannopoulos P; Davies GJ; Lammertsma AA; Jones T; Maseri A
    Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects.
    Succurro E; Miceli S; Fiorentino TV; Sciacqua A; Perticone M; Andreozzi F; Sesti G
    Cardiovasc Diabetol; 2021 Mar; 20(1):60. PubMed ID: 33676510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.
    Mather KJ; Considine RV; Hamilton L; Patel NA; Mathias C; Territo W; Goodwill AG; Tune JD; Green MA; Hutchins GD
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3456-3465. PubMed ID: 30020461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.
    Kim G; Jo K; Kim KJ; Lee YH; Han E; Yoon HJ; Wang HJ; Kang ES; Yun M
    Cardiovasc Diabetol; 2015 Nov; 14():148. PubMed ID: 26538247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?
    Hughes GC; Landolfo CK; Yin B; DeGrado TR; Coleman RE; Landolfo KP; Lowe JE
    Ann Thorac Surg; 2001 Jul; 72(1):163-8. PubMed ID: 11465172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.